The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 19.37% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -0.22%. Over the past 30 days, the price of ABT has leaped by -0.76%. And in the last five days, it has surged by 0.25%.
The stock of Abbott Laboratories (ABT) is currently priced at $131.02. In the last session, the stock climbed significantly, topping out at $159.0 after opening at $131.02. The day’s lowest price was $122.0 before the stock closed at $131.36.
Abbott Laboratories experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $141.23 on 03/04/25, while the lowest price for the same period was registered at $107.11 on 08/13/24.
52-week price history of ABT Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Abbott Laboratories’s current trading price is -7.23% away from its 52-week high, while its distance from the 52-week low is 22.33%. The stock’s price range during this time has been between $107.11 and $141.23. The trading volume for the Healthcare sector company’s shares reached about 5.66 million for the day, which was lower than the average daily volume of 6.63 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Abbott Laboratories (ABT) has experienced a quarterly decline of -0.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 228.03B and boasts a workforce of 114000 employees.
Abbott Laboratories: Analysts’ Ratings Unveiled
As of right now, 14 analysts are rating Abbott Laboratories as a BUY, 6 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 130.98, with a change in price of +3.60. Similarly, Abbott Laboratories recorded 6,875,640 in trading volume during the last 100 days, posting a change of +2.83%.
ABT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ABT stands at 0.27. Similarly, the long-term debt-to-equity ratio is also 0.26.
ABT Stock Stochastic Average
Today’s raw stochastic average for Abbott Laboratories over the last 50 days is 58.32%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 75.30%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 83.33% and 85.87%, respectively.
